The Rise of Agentic AI: Transforming Healthcare and Business Operations
June 3, 2025, 3:53 am
Location: United States, New York
Employees: 1001-5000
Founded date: 2011
Total raised: $1.39B
Location: United States, Illinois, Chicago
Employees: 501-1000
Founded date: 2013
Total raised: $270.83M
In the world of technology, change is the only constant. The rise of agentic AI is a prime example. This new wave of artificial intelligence is not just about automation; it’s about creating intelligent systems that can operate independently. Two recent announcements highlight this trend: ConcertAI’s integration of ASCO guidelines into its oncology solutions and UiPath’s partnership with HCLTech to enhance agentic automation for global enterprises.
ConcertAI is a leader in oncology AI solutions. Their latest move involves integrating the American Society of Clinical Oncology (ASCO) guidelines into their Precision Suite and CancerLinQ SmartLinQ solutions. This integration is a game-changer. It allows biopharma researchers to access real-time data on guideline-concordant care. Imagine having a compass that always points to the best treatment options. That’s what ConcertAI is offering.
The Precision Suite is designed for speed and accuracy. It provides low-latency data, which means oncologists can make informed decisions quickly. The integration of ASCO guidelines will enhance the SmartLinQ solutions, giving oncologists tailored recommendations for their patients. This is not just about data; it’s about improving patient outcomes. With the right information at their fingertips, healthcare providers can navigate the complex landscape of cancer treatment more effectively.
In December 2023, ConcertAI acquired CancerLinQ, a significant step in their journey. This partnership has already led to advancements in the SmartLinQ application. The platform now offers notifications for beneficial diagnostics and newly approved therapeutics. It’s like having a personal assistant that keeps you updated on the latest developments in cancer care. By June 30, 2025, the ASCO guidelines will be fully integrated, providing a comprehensive resource for oncologists.
On the other side of the tech spectrum, UiPath is making waves in the business world. Their recent partnership with HCLTech aims to accelerate agentic automation across various industries. This collaboration is about more than just streamlining processes; it’s about creating intelligent systems that can operate with minimal human intervention. Picture a factory where machines not only perform tasks but also learn and adapt. That’s the vision UiPath and HCLTech are bringing to life.
HCLTech will leverage its AI expertise to deploy the UiPath Platform, enabling autonomous operations in finance, supply chain, and customer service. This partnership is set to enhance business agility and optimize workforce efficiency. Companies will see faster returns on their automation investments. It’s like upgrading from a bicycle to a high-speed train. The journey becomes quicker and more efficient.
The establishment of an AI Lab in India is another exciting development. This lab will focus on creating Industry Focused Repeatable Solutions (IFRS) and Minimum Viable Products (MVPs) for the full automation lifecycle. From strategy to implementation, this lab will be a hub of innovation. It’s a breeding ground for ideas that can transform how businesses operate.
As we move into this new era of agentic AI, the implications are profound. Businesses will gain unprecedented efficiency and agility. The ability to adapt quickly to changing market conditions will be a game-changer. Companies that embrace this technology will unlock new business potential. It’s like having a secret weapon in a competitive landscape.
The partnership between UiPath and HCLTech is a testament to the power of collaboration. By combining their strengths, they are setting new benchmarks for agentic autonomous operations. This is not just about technology; it’s about reshaping industries. The future of work is here, and it’s powered by intelligent automation.
In healthcare, the integration of ASCO guidelines into ConcertAI’s solutions is a significant step forward. It empowers oncologists with the tools they need to provide high-quality care. The focus is on evidence generation and advanced care insights. This is a shift from reactive to proactive care. It’s about anticipating patient needs and responding with precision.
Both ConcertAI and UiPath are leading the charge in their respective fields. They are harnessing the power of AI to create solutions that are not only innovative but also impactful. The integration of guidelines in healthcare and the acceleration of automation in business are just the beginning. As these technologies evolve, they will continue to reshape our world.
In conclusion, the rise of agentic AI is transforming both healthcare and business operations. ConcertAI’s integration of ASCO guidelines is revolutionizing cancer care, while UiPath’s partnership with HCLTech is redefining automation. These advancements are not just technological; they are paving the way for a future where intelligent systems enhance human capabilities. The journey has just begun, and the possibilities are limitless. Embrace the change, for it is the dawn of a new era.
ConcertAI is a leader in oncology AI solutions. Their latest move involves integrating the American Society of Clinical Oncology (ASCO) guidelines into their Precision Suite and CancerLinQ SmartLinQ solutions. This integration is a game-changer. It allows biopharma researchers to access real-time data on guideline-concordant care. Imagine having a compass that always points to the best treatment options. That’s what ConcertAI is offering.
The Precision Suite is designed for speed and accuracy. It provides low-latency data, which means oncologists can make informed decisions quickly. The integration of ASCO guidelines will enhance the SmartLinQ solutions, giving oncologists tailored recommendations for their patients. This is not just about data; it’s about improving patient outcomes. With the right information at their fingertips, healthcare providers can navigate the complex landscape of cancer treatment more effectively.
In December 2023, ConcertAI acquired CancerLinQ, a significant step in their journey. This partnership has already led to advancements in the SmartLinQ application. The platform now offers notifications for beneficial diagnostics and newly approved therapeutics. It’s like having a personal assistant that keeps you updated on the latest developments in cancer care. By June 30, 2025, the ASCO guidelines will be fully integrated, providing a comprehensive resource for oncologists.
On the other side of the tech spectrum, UiPath is making waves in the business world. Their recent partnership with HCLTech aims to accelerate agentic automation across various industries. This collaboration is about more than just streamlining processes; it’s about creating intelligent systems that can operate with minimal human intervention. Picture a factory where machines not only perform tasks but also learn and adapt. That’s the vision UiPath and HCLTech are bringing to life.
HCLTech will leverage its AI expertise to deploy the UiPath Platform, enabling autonomous operations in finance, supply chain, and customer service. This partnership is set to enhance business agility and optimize workforce efficiency. Companies will see faster returns on their automation investments. It’s like upgrading from a bicycle to a high-speed train. The journey becomes quicker and more efficient.
The establishment of an AI Lab in India is another exciting development. This lab will focus on creating Industry Focused Repeatable Solutions (IFRS) and Minimum Viable Products (MVPs) for the full automation lifecycle. From strategy to implementation, this lab will be a hub of innovation. It’s a breeding ground for ideas that can transform how businesses operate.
As we move into this new era of agentic AI, the implications are profound. Businesses will gain unprecedented efficiency and agility. The ability to adapt quickly to changing market conditions will be a game-changer. Companies that embrace this technology will unlock new business potential. It’s like having a secret weapon in a competitive landscape.
The partnership between UiPath and HCLTech is a testament to the power of collaboration. By combining their strengths, they are setting new benchmarks for agentic autonomous operations. This is not just about technology; it’s about reshaping industries. The future of work is here, and it’s powered by intelligent automation.
In healthcare, the integration of ASCO guidelines into ConcertAI’s solutions is a significant step forward. It empowers oncologists with the tools they need to provide high-quality care. The focus is on evidence generation and advanced care insights. This is a shift from reactive to proactive care. It’s about anticipating patient needs and responding with precision.
Both ConcertAI and UiPath are leading the charge in their respective fields. They are harnessing the power of AI to create solutions that are not only innovative but also impactful. The integration of guidelines in healthcare and the acceleration of automation in business are just the beginning. As these technologies evolve, they will continue to reshape our world.
In conclusion, the rise of agentic AI is transforming both healthcare and business operations. ConcertAI’s integration of ASCO guidelines is revolutionizing cancer care, while UiPath’s partnership with HCLTech is redefining automation. These advancements are not just technological; they are paving the way for a future where intelligent systems enhance human capabilities. The journey has just begun, and the possibilities are limitless. Embrace the change, for it is the dawn of a new era.